- Article
Investigation into the Optimal Strategy of Radium-223 Therapy for Metastatic Castration-Resistant Prostate Cancer
- Yasuo Oguma,
- Makoto Hosono,
- Kaoru Okajima,
- Eri Inoue,
- Kiyoshi Nakamatsu,
- Hiroshi Doi,
- Tomohiro Matsuura,
- Masahiro Inada,
- Takuya Uehara and
- Yutaro Wada
- + 5 authors
The optimal sequence and combination of radium-223 therapy (Ra-223) for castration-resistant prostate cancer with bone metastasis (mCRPC) remain unclear. This study aimed to explore the prognostic factors after Ra-223 administration and to determine...

